SZSE Ticker: 002332

Zhejiang Xianju Pharmaceutical Co., Ltd.

浙江仙琚制药股份有限公司

仙琚制药

XJZY

Listing Date: 2010-01-12

Board: SME

Industry Classification: Manufacturing

China Universal High-end Manufacturing Stock A Net Value Up 4.15% China Universal

China Universal High-end Manufacturing Stock A Net Value Up 4.15% China Universal

China Universal High-end Manufacturing Stock A Net Value Up 4.69% China Universal

China Universal High-end Manufacturing Stock A Net Worth Down 5.13% China Universal

[Graphic Quarterly Report] Comments on the 2022 First Quarterly Report of China Universal Healthcare Hybrid A Fund_Oriental Fortune Network

Highlights of Important Announcements of Listed Companies: Shenzhen Stock Exchange Terminates × ST Iger's Listing, No Delisting Arrangement Period_Shenzhen Hotline

[Good News Express] The China Banking and Insurance Regulatory Commission has increased its logistics support, it is expected that the pig company will reach breakeven in June, and the net profit of Asymchem in the first quarter has more than doubled

Highlights of Important Announcements of Listed Companies on April 21: Shenzhen Stock Exchange Terminates *ST Iger's Listing without Setting a Delisting Arrangement Period_Oriental Fortune Network

Highlights of Important Announcements of Listed Companies on April 21: Shenzhen Stock Exchange Terminates *ST Iger's Listing, No Delisting Arrangement Period

Xianju Pharmaceutical: Net profit in 2021 is about 616 million yuan, an increase of 22.09% year-on-year

Xianju Pharmaceutical (002332.SZ) released its 2021 results, with a net profit of 616 million yuan, a year-on-year increase of 22.09%, and plans to distribute 1.5 yuan in 10 distributions.

Xianju Pharmaceutical (002332.SZ) released its 2021 results, with a net profit of 616 million yuan, a year-on-year increase of 22.09%, and planned 10 distributions of 1.5 yuan – yqqlm

Xianju Pharmaceutical: Net profit in 2021 is about 616 million yuan, a year-on-year increase of 22.09%_Oriental Fortune Net

Xianju Pharmaceutical announced the 2021 annual equity distribution plan to distribute 1.5 yuan in 10 distributions

Xianju Pharmaceutical: Net profit in 2021 will increase by 22.09% year-on-year, and 10 distributions of 1.5 yuan are planned

Xianju Pharmaceutical released its 2021 results, with a net profit of 616 million yuan, a year-on-year increase of 22.09%, and plans to distribute 1.5 yuan per ten

Xianju Pharmaceutical: Net profit in 2021 will increase by 22.09% year-on-year, and 10 distributions of 1.5 yuan are planned jqknews

Xianju Pharmaceutical: Net profit in 2021 will increase by 22.09% year-on-year, and 10 distributions of 1.5 yuan are planned – yqqlm

Heavy plans have been introduced one after another, and the output value of this golden track is nearly 5 trillion! There are only 20 consecutive high-growth stocks, and half of the stocks have a price-earnings ratio of less than 30 times

Yongying Medical and Health stock A net value fell 4.06% stock_Sina Finance_Sina.com

Yongying Medical and Health's stock C net value fell 4.05%_Sina Finance_Sina.com

Want to see more data? Registered subscribers can see all the data.